2019
DOI: 10.1128/jvi.00257-19
|View full text |Cite|
|
Sign up to set email alerts
|

Interferon Gamma Inhibits Varicella-Zoster Virus Replication in a Cell Line-Dependent Manner

Abstract: The major immediate early 62 (IE62) protein of varicella-zoster virus (VZV) is delivered to newly infected cell nuclei, where it initiates VZV replication by transactivating viral immediate early (IE), early (E), and late (L) genes. Interferon gamma (IFN-γ) is a potent cytokine produced following primary VZV infection. Furthermore, VZV reactivation correlates with a decline in IFN-γ-producing immune cells. Our results showed that treatment with 20 ng/ml of IFN-γ completely reduced intracellular VZV yield in A5… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
36
0
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 25 publications
(40 citation statements)
references
References 75 publications
(94 reference statements)
3
36
0
1
Order By: Relevance
“…IFN-c-IRF1 axis was more potent than IFN-a-IRF9 axis in blocking VZV infection of primary human fibroblasts [60]. Conversely, in some cell lines (e.g., MeWo melanoma cells), IFN-b, but not IFN-c, exerted an anti-VZV activity [61]. The defensive role of type I IFN against VZV infection is also supported by a clinical trial revealing an increased incidence of herpes zoster with the use of anifrolumab, a human anti-type I IFN receptor monoclonal antibody, for patients with systemic lupus erythematosus [62].…”
Section: Ifn-c In Varicella Zoster Virus (Vzv) Infectionmentioning
confidence: 91%
See 1 more Smart Citation
“…IFN-c-IRF1 axis was more potent than IFN-a-IRF9 axis in blocking VZV infection of primary human fibroblasts [60]. Conversely, in some cell lines (e.g., MeWo melanoma cells), IFN-b, but not IFN-c, exerted an anti-VZV activity [61]. The defensive role of type I IFN against VZV infection is also supported by a clinical trial revealing an increased incidence of herpes zoster with the use of anifrolumab, a human anti-type I IFN receptor monoclonal antibody, for patients with systemic lupus erythematosus [62].…”
Section: Ifn-c In Varicella Zoster Virus (Vzv) Infectionmentioning
confidence: 91%
“…Given the findings that patients with multiple myeloma, which is associated with humoral immunity defects, present with increased herpes zoster incidence only after treatment with the proteasome inhibitor bortezomib [59], cell-mediated immunity may play a greater role than humoral immunity in the host defense against VZV. Both type I IFN and IFN-c have been shown to act on the cells to restrict VZV replication and spread [60,61]. IFN-c-IRF1 axis was more potent than IFN-a-IRF9 axis in blocking VZV infection of primary human fibroblasts [60].…”
Section: Ifn-c In Varicella Zoster Virus (Vzv) Infectionmentioning
confidence: 99%
“…Another recent report indicates there are cell type specific activities in the relative ability of IFNβ and IFNγ to limit virus production. IFNγ could profoundly inhibit VZV production in ARPE-19, A549, MRC-5 but had only very limited capacity to inhibit infection in MeWo cells, where IFNβ retained the capacity to significantly reduce viral yield (120). IFNγ could also promote survival of VZV infected neurons to potentially ensure the efficient establishment of latency (121).…”
Section: Vzv Modulation Of Ifn In Immune Cellsmentioning
confidence: 99%
“…Survivin, which is abundant in cancers and tissues that contain proliferating cells, mediates a necessary virusenhancing effect of STAT3 activation on VZV [426]. The major IE-62 protein of VZV is delivered to the newly infected cell nuclei where it initiates VZV replication [429]. IE-62 protein is the predominant VZ virion tegument protein [427].…”
Section: Signaling Pathwaysmentioning
confidence: 99%
“…IE-62 protein is the predominant VZ virion tegument protein [427]. It activates the expression of all kinetic classes of VZV genes [427,429]. IFN-γ blocks VZV replication by inhibiting IE-62 function in a cell line-dependent manner [429].…”
Section: Signaling Pathwaysmentioning
confidence: 99%